Bafna Pharmaceuticals Limited (BOM:532989)
India flag India · Delayed Price · Currency is INR
163.35
+6.85 (4.38%)
At close: Jun 19, 2026

Bafna Pharmaceuticals Statistics

Total Valuation

BOM:532989 has a market cap or net worth of INR 3.79 billion. The enterprise value is 4.14 billion.

Market Cap3.79B
Enterprise Value 4.14B

Important Dates

The last earnings date was Friday, May 29, 2026.

Earnings Date May 29, 2026
Ex-Dividend Date n/a

Share Statistics

Current Share Class 23.66M
Shares Outstanding n/a
Shares Change (YoY) +0.05%
Shares Change (QoQ) +0.63%
Owned by Insiders (%) 4.97%
Owned by Institutions (%) 4.36%
Float 3.34M

Valuation Ratios

The trailing PE ratio is 34.14.

PE Ratio 34.14
Forward PE n/a
PS Ratio 2.52
PB Ratio 3.94
P/TBV Ratio 3.94
P/FCF Ratio n/a
P/OCF Ratio 24.65
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings 37.33
EV / Sales 2.75
EV / EBITDA 25.98
EV / EBIT 41.96
EV / FCF n/a

Financial Position

The company has a current ratio of 1.57, with a Debt / Equity ratio of 0.39.

Current Ratio 1.57
Quick Ratio 0.80
Debt / Equity 0.39
Debt / EBITDA 2.35
Debt / FCF -3.93
Interest Coverage 2.70

Financial Efficiency

Return on equity (ROE) is 12.27% and return on invested capital (ROIC) is 7.75%.

Return on Equity (ROE) 12.27%
Return on Assets (ROA) 3.76%
Return on Invested Capital (ROIC) 7.75%
Return on Capital Employed (ROCE) 8.34%
Weighted Average Cost of Capital (WACC) n/a
Revenue Per Employee 3.71M
Profits Per Employee 273,394
Employee Count406
Asset Turnover 0.92
Inventory Turnover 3.60

Taxes

Income Tax -1.30M
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +108.67% in the last 52 weeks.

Beta (5Y) n/a
52-Week Price Change +108.67%
50-Day Moving Average 143.04
200-Day Moving Average 134.77
Relative Strength Index (RSI) 55.50
Average Volume (20 Days) 7,499

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, BOM:532989 had revenue of INR 1.51 billion and earned 111.00 million in profits. Earnings per share was 4.69.

Revenue1.51B
Gross Profit 481.34M
Operating Income 98.75M
Pretax Income 109.70M
Net Income 111.00M
EBITDA 159.48M
EBIT 98.75M
Earnings Per Share (EPS) 4.69
Full Income Statement

Balance Sheet

The company has 20.25 million in cash and 374.33 million in debt, with a net cash position of -354.09 million.

Cash & Cash Equivalents 20.25M
Total Debt 374.33M
Net Cash -354.09M
Net Cash Per Share n/a
Equity (Book Value) 961.50M
Book Value Per Share 40.57
Working Capital 324.63M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 153.71 million and capital expenditures -249.03 million, giving a free cash flow of -95.32 million.

Operating Cash Flow 153.71M
Capital Expenditures -249.03M
Depreciation & Amortization 60.73M
Net Borrowing 92.35M
Free Cash Flow -95.32M
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross margin is 31.96%, with operating and profit margins of 6.56% and 7.37%.

Gross Margin 31.96%
Operating Margin 6.56%
Pretax Margin 7.28%
Profit Margin 7.37%
EBITDA Margin 10.59%
EBIT Margin 6.56%
FCF Margin n/a

Dividends & Yields

BOM:532989 does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -0.05%
Shareholder Yield -0.05%
Earnings Yield 2.93%
FCF Yield -2.52%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 5